OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PHOE58

Phoenix Financial Ltd

Life & Health InsuranceVerified

Phoenix Financial Ltd maintains a liquidity position with a cash and equivalents balance of 2.53 billion ILS, representing 12.8% of total assets, and a debt-to-equity ratio of 1.02, indicating a balanced capital structure. The company's free cash flow of 1.65 billion ILS and operating cash flow of 4.2 billion ILS support its liquidity position, though its operating income is negative at -13.31 billion ILS. The company's profitability is mixed, with a return on equity (ROE) of 25.79%, which is strong, but a return on assets (ROA) of 1.63%, which is relatively low. This suggests that while the company is effectively using equity to generate returns, it is less efficient in utilizing its total assets to produce profit. Phoenix Financial Ltd's revenue is concentrated in the life and health insurance segment, with no disclosed geographic breakdown. The company's exposure is primarily to the insurance market, and there is no indication of significant diversification across product lines or regions. The company's growth trajectory is uncertain, with no specific revenue growth projections provided. However, the negative operating income of -13.31 billion ILS indicates a current challenge in maintaining profitability, which could affect future growth. The risk assessment for Phoenix Financial Ltd indicates low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure and cash flow position support its liquidity, and there is no indication of near-term dilution pressure. Recent events and filings do not show any significant changes or developments that would impact Phoenix Financial Ltd's operations or financial position. The company's financial snapshot and risk assessment suggest a stable, though not highly dynamic, business environment.

30-day price · PHOE+3580.00 (+21.9%)
Low$16220.00High$20130.00Close$19890.00As of25 May, 00:00 UTC
Profile
CompanyPhoenix Financial Ltd
TickerPHOE.TA
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Phoenix Financial Ltd provides life and health insurance products and services, generating revenue primarily through premium income and investment returns on its insurance reserves.

Classification. Phoenix Financial Ltd is classified under the Life & Health Insurance industry within the Insurance business sector, with a classification confidence of 0.92.

Phoenix Financial Ltd maintains a liquidity position with a cash and equivalents balance of 2.53 billion ILS, representing 12.8% of total assets, and a debt-to-equity ratio of 1.02, indicating a balanced capital structure. The company's free cash flow of 1.65 billion ILS and operating cash flow of 4.2 billion ILS support its liquidity position, though its operating income is negative at -13.31 billion ILS. The company's profitability is mixed, with a return on equity (ROE) of 25.79%, which is strong, but a return on assets (ROA) of 1.63%, which is relatively low. This suggests that while the company is effectively using equity to generate returns, it is less efficient in utilizing its total assets to produce profit. Phoenix Financial Ltd's revenue is concentrated in the life and health insurance segment, with no disclosed geographic breakdown. The company's exposure is primarily to the insurance market, and there is no indication of significant diversification across product lines or regions. The company's growth trajectory is uncertain, with no specific revenue growth projections provided. However, the negative operating income of -13.31 billion ILS indicates a current challenge in maintaining profitability, which could affect future growth. The risk assessment for Phoenix Financial Ltd indicates low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure and cash flow position support its liquidity, and there is no indication of near-term dilution pressure. Recent events and filings do not show any significant changes or developments that would impact Phoenix Financial Ltd's operations or financial position. The company's financial snapshot and risk assessment suggest a stable, though not highly dynamic, business environment.
Key takeaways
  • Phoenix Financial Ltd has a strong return on equity (25.79%) but a low return on assets (1.63%), indicating efficient use of equity but less efficient use of total assets.
  • The company maintains a balanced capital structure with a debt-to-equity ratio of 1.02 and a liquidity position supported by 2.53 billion ILS in cash and equivalents.
  • Phoenix Financial Ltd's revenue is concentrated in the life and health insurance segment, with no disclosed geographic diversification.
  • The company's negative operating income of -13.31 billion ILS suggests current challenges in maintaining profitability.
  • Analysts have a strong buy recommendation for Phoenix Financial Ltd, with a mean price target of 175.00 ILS.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyILS
Revenue
Gross profit
Operating income-$13.31B
Net income$3.22B
R&D
SG&A
D&A
SBC
Operating cash flow$4.20B
CapEx-$757.2M
Free cash flow$1.65B
Total assets$197.94B
Total liabilities$185.44B
Total equity$12.50B
Cash & equivalents$25.28B
Long-term debt$12.80B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$12.50B
Net cash$12.48B
Current ratio
Debt/Equity1.0
ROA1.6%
ROE25.8%
Cash conversion1.3%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricPHOEActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity102.0%27.5% medp25 4.7% · p75 66.5%top quartile
Observations
IR observations
Mean price target175.00 ILS
Median price target175.00 ILS
High price target175.00 ILS
Low price target175.00 ILS
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate13.30 ILS
Last actual EPS12.60 ILS
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-23 00:40 UTC#0ddc8af5
Market quoteclose ILS 18650.00 · shares 0.25B diluted
no public URL
2026-05-23 00:41 UTC#004ea268
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 23:36 UTCJob: 998658a4